ALZAMEND NEURO INC. - COMMON STOCK

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

25 3月 2025 08:00:01 条件 Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

18 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

11 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

04 3月 2025 08:10:00 条件 Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

25 2月 2025 08:00:59 条件 Nasdaq GlobeNewswire